The Food and Drug Administration has warned Novo Nordisk that a television advertisement promoting its newly launched Wegovy pill for obesity contains “false or misleading” claims, saying the spot misbrands the drug and violates federal law, CNBC reported Monday.[#item_full_content]
FDA: Novo Nordisk’s Obesity Pill Ad Is Misleading
